Traditionally, adhesive capsulitis (AC) of the shoulder has been regarded as a self-limiting condition without significant long-term sequelae, lasting 18 or 30 months. However, several studies have reported long-term residual motion restriction and persisting symptoms in AC.[@B1][@B2] Reeves[@B1] reported that 50% of patients were still experiencing pain or stiffness of the shoulder at a mean of 7 years from the onset of the condition, although only 11% reported functional limitation. To decrease time to recovery and improve the outcomes, a variety of regimens have been used for the treatment of AC, which include nonsteroidal anti-inflammatory drugs, local intra-articular steroid injection, physiotherapy, hydrodilation, manipulation under anesthesia (MUA), and arthroscopic capsular release (ACR).[@B3][@B4][@B5][@B6][@B7][@B8]

Among these regimens, MUA has been the long-standing treatment for refractory AC. Numerous studies have reported this approach as a safe and effective treatment for reducing the duration of symptoms in patients with AC[@B3][@B6][@B9][@B10][@B11][@B12][@B13][@B14][@B15]; however, others have stated that MUA has no advantages compared with conservative treatment.[@B16][@B17][@B18] Also, the potential complications associated with this procedure (e.g., recurrent stiffness, fractures, dislocation, brachial plexus injury, and rotator cuff tear) have been documented.[@B8][@B19][@B20]

Because of recent advances in arthroscopic techniques, ACR has shown promising results comparable to those of other treatment options.[@B21][@B22][@B23][@B24] Although both MUA and ACR appear to be effective treatments in patients with refractory AC, it is unclear whether there is a difference in the clinical effectiveness of MUA compared to ACR. No comparative studies have evaluated clinical outcomes of both procedures. The aims of AC treatment are to eliminate pain and to recover range of motion (ROM) as soon as possible. Because it is important to report early clinical outcomes after procedures in addition to final clinical outcomes, we focused on the early response to MUA. Therefore, the purpose of this study was to compare early clinical outcomes between MUA and ACR in patients with AC. We hypothesized that MUA and ACR would have equivalent clinical outcomes.

METHODS
=======

Subjects
--------

The protocol of this study was reviewed and approved by Institutional Review Board of Dongsan Medical Center (IRB No. 2018-09-003). Written informed consents were obtained. Thirty-one patients underwent MUA for refractory AC in a single institution between 2016 and 2017. One patient was excluded from this study because she received ACR due to worse results at 3 months after MUA. In the MUA group, there were 21 female and nine male patients with a mean age of 54.5 years (range, 43--74 years). The dominant arm was affected in 19 patients. Eleven patients had a history of diabetes mellitus. The mean duration of symptoms was 12.1 months (range, 4--40 months). From the pool of patients who underwent ACR between 2007 and 2015, 30 patients who were matched for age and sex with the MUA group were included as a control group.

The inclusion criteria included a diagnosis of AC, defined as limitation of motion by greater than 50% in at least two planes (compared to the unaffected shoulder), absence of intrinsic or extrinsic shoulder disease confirmed by magnetic resonance imaging (MRI) or ultrasonography, and unsuccessful nonoperative management (e.g., medications, steroid injections, or physical therapy) for at least 3 months. Exclusion criteria were secondary AC with a rotator cuff tear, calcific tendinitis, osteoarthritis, inflammatory arthritis, and postsurgical, posttraumatic, or cervical disc disorder.

Manipulation under Anesthesia
-----------------------------

A propofol anesthetic was administered by manual mask ventilation with the patient in the supine position without any special muscle relaxant. All procedures were performed by a single surgeon (CHC). With the scapular stabilized to the posterior part of the chest, the shoulder was moved into forward elevation in the sagittal plane first, then into abduction, by applying gentle pressure to break the adhesions. Subsequently, external and internal rotations were performed in three different grades of abduction (0°, 45°, and 90°). To minimize the risks of humeral fractures, all manipulations were performed with the use of a short lever arm. In all cases, under fluoroscopic guidance, an 18-gauge spinal needle was inserted at the glenohumeral joint. The needle was joined to a connection containing an iodinated contrast medium, and the agent was injected to confirm the exact intra-articular location of the needle. After the position of the needle was confirmed, a mixture of 1mL triamcinolone (40 mg of methylprednisolone acetate), 10 mL 1% lidocaine, and 20 mL saline solution was injected to the capsule.[@B16]

Arthroscopic Capsular Release
-----------------------------

With the patient under general anesthesia, we assessed the ROM of the shoulder and then performed the same protocol of MUA. Afterwards, patients were placed in the lateral decubitus position, and we started a standard arthroscopic glenohumeral examination through the posterior portals. After confirmation of capsular thickening or synovial hypertrophy, we performed synovial ablation and capsular release by using an electrocautery and a shaver. The sequential capsular release began below the biceps tendon origin and superior capsule, the rotator interval, and coracohumeral ligament up to the base of the coracoid process, the anterior capsule, and the inferior capsule involving both the anterior and posterior bands of the inferior glenohumeral ligament. Finally, the posterior capsule was released through the anterior viewing portal and posterior working portal. The operation was finished after intra-articular injection of 1-mL triamcinolone (40 mg of methylprednisolone acetate).[@B22]

Postoperative Rehabilitation
----------------------------

Both groups received the same postoperative rehabilitation protocol. All patients were engaged in a rehabilitation program including pendulum exercises and immediate passive ROM exercises after procedure.

Assessment of Clinical Outcomes
-------------------------------

All patients were evaluated during a 12-month follow-up period. The evaluation of clinical outcomes was conducted by an independent research coordinator (EJJ). The visual analog scale (VAS) pain score and American Shoulder and Elbow Surgeons (ASES) score were assessed. ROM including forward flexion, external rotation with the arm at the side, and internal rotation at the back was also assessed. For statistical analysis of internal rotation, we converted values into contiguously numbered groups: T1 through T12 into 1 through 12; L1 through L5 into 13 through 17; sacrum into 18; and buttock into 19. Assessments were performed preoperatively at 3, 6, and 12 months after procedure.

Statistical Analysis
--------------------

IBM SPSS ver. 23.0 (IBM Corp., Armonk, NY, USA) was used for data analysis. Sample size was calculated by using the difference of ASES scores between the two groups at 3 months after procedure. To obtain the large effect size of 0.85, a minimum of 30 patients for each group was required (two-sided α error of 0.05 and β error of 0.15). To determine the significance of differences between the groups, we used the chi-square test, Fisher exact test, and Mann-Whitney *U*-test. To evaluate the serial changes in outcome measurements including the VAS pain score, ASES score, and ROMs, we used the Mann-Whitney *U*-test and repeated-measures analysis of variance. A *p* \< 0.05 was considered to represent a statistically significant difference.

RESULTS
=======

Demographics of patients are summarized in [Table 1](#T1){ref-type="table"}. There were no significant differences between the two groups in terms of mean age, sex, affected side, presence of diabetes mellitus, duration of symptoms, preoperative VAS pain score, ASES score, and ROMs (*p* \> 0.05).

VAS pain score and ASES score significantly improved in both groups during the serial follow-up period (*p* \< 0.001). There were no statistically significant differences between the two groups in most of the assessed clinical scores. However, the mean VAS pain score in the MUA group was significantly lower than that in the ACR group at 3 months after procedure (1.6 vs. 3.4, *p* \< 0.001), and the ASES score in the MUA group was higher than in the ACR group at 3 months after procedure (80.3 vs. 66.1, *p* \< 0.001) ([Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).

There were no significant differences between the two groups in terms of preoperative forward flexion, external rotation, and internal rotation (*p* \> 0.05). Both groups had significant improvement in the ROMs of the shoulder joint at the final follow-up compared with the preoperative ROMs (*p* \< 0.001). In the MUA group, mean forward flexion was significantly greater than that in the ACR group at 3 months after procedure (156.3° vs. 148.6°, *p* = 0.011) ([Fig. 3](#F3){ref-type="fig"}). Mean external rotation and internal rotation were significantly greater than those in the ACR group at 3 months (60.6° vs. 38.2°, *p* \< 0.001 and 11.0 vs 14.4, *p* \< 0.001, respectively), 6 months (66.2° vs 51.0°, *p* \< 0.001 and 10.4 vs. 12.3, *p* = 0.015, respectively), and 12 months (73.0° vs. 61.3°, *p* \< 0.001 and 9.0 vs. 10.7, *p* = 0.042, respectively) after procedure ([Figs. 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}).

No serious complications including instability, iatrogenic fracture, brachial plexus injury, and infection were encountered in either group. In the MUA group, however, two patients required additional intra-articular steroid injection at 3 and 6 months after MUA for recurrent stiffness with pain. After reinjection, these patients achieved satisfactory results at the final follow-up.

DISCUSSION
==========

The most important finding of this study is that compared with ACR, MUA provided equivalent clinical outcomes without major complications in the early period after procedure. In particular, the MUA group achieved earlier restoration of ROM during the follow-up period after the procedure. We think there are two reasons for the above results. First, MUA may obviate the unnecessary surgical damage caused by arthroscopic surgery. Even though we had two patients who needed additional steroid injection because of recurrence, most patients who underwent MUA had a good outcome without complications. Second, although there was no significant difference in preoperative clinical scores between groups, the VAS score was slightly higher and ROM was more limited in the ACR group than in the MUA group. These worse preoperative conditions may have affected postoperative results.

Numerous studies have reported that MUA in patients with refractory AC produces overall satisfactory clinical outcomes.[@B3][@B6][@B9][@B10][@B11][@B12][@B13][@B14][@B15] Dodenhoff et al.[@B3] documented that the mean Constant score of 37 patients with MUA rose from 24 to 63 at 3 weeks and to 67 at 3 months. Overall, 94% of patients were satisfied with the procedure. They recommended the use of MUA in refractory AC to restore early ROM and improve early function. Tsvieli et al.[@B12] concluded that MUA results in dramatic early improvement in ROM and functional outcomes with high satisfaction. The proponents of MUA emphasized that the major role of MUA is to shorten this time span and to achieve an early pain-free functional ROM in the shoulder. They also asserted satisfactory maintenance of results in the long-term follow-up.

On the other hand, several studies have reported that MUA confers no advantages compared to conservative treatment.[@B16][@B17][@B18] Kivimaki et al.[@B17] compared the effects between MUA with home exercise and home exercise alone in the treatment of AC. At 6 weeks, 3, 6, and 12 months, both groups did not differ at any period of the follow-up in terms of working ability and pain. They concluded that MUA in patients with AC did not confer any additional benefits compared with a home exercise program. Furthermore, the potential complications associated with MUA (e.g., recurrent stiffness, fractures, dislocation, brachial plexus injury, and rotator cuff tear) have been reported.[@B8][@B19][@B20] Jacobs et al.[@B16] recommended the use of steroid injection as an optimal treatment option for AC and reported the relative ease and safety of steroid with distension injections.

ACR has been well known as an effective option that can be applied to patients who have failed conservative treatment.[@B21][@B22][@B23][@B24] De Carli et al.[@B23] showed that compared to an intra-articular steroid injection, an ACR with MUA provided significant improvement at 6-week follow-up. Cvetanovich et al.[@B22] reported that ACR for idiopathic AC provided significant early and lasting improvement in ROM, excellent functional outcomes, and low revision and complication rates. Although MUA and ACR both appear to be effective treatments capable of providing a rapid improvement in patients with refractory AC, it is unclear whether there is a difference in the clinical effectiveness of MUA compared to ACR. According to a systematic review of 22 clinical trials, which included 989 patients, there was no clear difference in shoulder ROM or patient-reported outcomes when comparing MUA to ACR for the treatment of refractory AC.[@B5] They concluded that the quality of evidence was low and the data available demonstrated a few benefits for ACR instead of, or in addition to, an MUA.

In the present study, we confirmed that compared with ACR, MUA provided equivalent clinical outcomes in the early period after procedure. MUA did not result in any complications in our cohort, except in two patients who required additional steroid injection at 3 and 6 months after MUA because of recurrent stiffness with pain. ACR is a costly inpatient procedure, whereas MUA can be carried out as a outpatient procedure. In light of our results, we believe that MUA can shorten the time required for recovery in patients with refractory AC, thereby reducing the economic and social burden produced by the lengthy disability.

This study has several limitations. It is a retrospective, comparative study with a relatively small sample size. Indications, especially the history of treatment, may have been different between MUA and ACR because this is a not prospective, randomized, controlled study and we did not routinely perform specific image testing such as MRI or ultrasonography on patients. One patient from the MUA group did not achieve improvement in ROM at 3 months and had subsequent arthroscopic release, and this patient was not included in our series. These factors might have affected serial comparison of clinical outcomes after procedure. Although the data of the study group were collected prospectively, the data of the control group were collected retrospectively. Nonetheless, the control group was matched according to sex and age, which could have minimized selective bias. Prospective, randomized, controlled trials are needed to compare the clinical, patient-reported, and cost outcomes of using either MUA or ACR to treat refractory AC.

In conclusion, compared with ACR, MUA offered equivalent clinical outcomes in the early period after the procedure. MUA in patients with refractory AC can be a simple and safe procedure to improve shoulder symptoms and function within a short period of time. It can be considered as a useful treatment option before choosing ACR.
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###### Demographic Data
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  Variable                             MUA group      ACR group     *p*-value
  ------------------------------------ -------------- ------------- -----------
  Age (yr)                             54.5 ± 7.7     55.3 ± 8.3    0.240
  Sex                                                               0.442
   Male                                9              9             
   Female                              21             21            
  Involved side                                                     0.349
   Dominant                            19             16            
   Nondominant                         11             14            
  History of diabetes mellitus         11             13            0.589
  Duration of symptoms (mo)            12.1 ± 8.7     11.4 ± 8.3    0.460
  Preoperative VAS pain score          6.8 ± 2.0      7.3 ± 1.4     0.791
  Preoperative ASES score              33.3 ± 15.5    28.4 ± 13.7   0.234
  Preoperative forward flexion (°)     100.0 ± 15.5   95.3 ± 18.0   0.652
  Preoperative external rotation (°)   18.5 ± 9.8     15.2 ± 10.8   0.178
  Preoperative internal rotation       16.3 ± 2.2     16.7 ± 1.9    0.605

Values are presented as mean ± standard deviation.

MUA: manipulation under anesthesia, ACR: arthroscopic capsular release, VAS: visual analog scale, ASES: American shoulder and elbow surgeons.
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